London Health Sciences Centre /ID# 171567

London, Ontario N6A 5A5

0 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Cancer

Studies at this site

• Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer — Withdrawn before enrolling